Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAIL, a mighty apoptosis inducer.

Youngleem Kim1, Dai-Wu Seol

  • 1Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

Molecules and Cells
|July 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy.

BMB reports·2020
Same author

No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants.

Experimental & molecular medicine·2019
Same author

Breathing New Life into TRAIL for Breast Cancer Therapy: Co-Delivery of pTRAIL and Complementary siRNAs Using Lipopolymers.

Human gene therapy·2019
Same author

Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers.

Oncotarget·2017
Same author

A novel minimal residual disease model of neuroblastoma in mice.

Journal of pediatric surgery·2016
Same author

DUSP6 is a novel transcriptional target of p53 and regulates p53-mediated apoptosis by modulating expression levels of Bcl-2 family proteins.

FEBS letters·2012
Same journal

Oxidative stress drives liver failure during in vivo partial reprogramming.

Molecules and cells·2026
Same journal

scpp5 regulates tooth development and injury-induced repair in zebrafish through mineralization and Wnt/β-catenin signaling.

Molecules and cells·2026
Same journal

Corrigendum to "Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling" [Mol. Cells 49 (2026) 100342].

Molecules and cells·2026
Same journal

Multiple ShKT domain-containing MUL-1 proteins act as redox-responsive modulators of oxidative stress signaling in C. elegans.

Molecules and cells·2026
Same journal

Small molecule inhibition of voltage dependent anion channel 1 reroutes mitochondrial metabolite flux.

Molecules and cells·2026
Same journal

Adherent-to-suspension transition modulates circulating tumor cell dynamics and metastatic potential in melanoma.

Molecules and cells·2026
See all related articles

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) effectively induces cancer cell death and limits tumor growth without harming normal tissues. TRAIL also plays a role in natural defense mechanisms, with its absence linked to autoimmune disorders.

Area of Science:

  • Molecular biology
  • Immunology
  • Cancer research

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a TNF-family cytokine.
  • TRAIL induces apoptosis in cancer cells and limits tumor growth in vivo.
  • TRAIL is implicated in natural immune defense and its abrogation is linked to autoimmune disorders.

Purpose of the Study:

  • To review recent advancements in TRAIL research.
  • To explore TRAIL's role in apoptotic signaling and its regulation.
  • To discuss potential therapeutic applications of TRAIL in cancer treatment.

Main Methods:

  • Literature review of recent TRAIL research.
  • Analysis of studies on TRAIL-mediated apoptosis.
  • Examination of TRAIL's role in autoimmune diseases.

Related Experiment Videos

Main Results:

  • TRAIL is a potent apoptosis inducer for various cancer cells.
  • TRAIL demonstrates efficacy in limiting tumor growth in vivo.
  • TRAIL deficiency is associated with autoimmune conditions.

Conclusions:

  • TRAIL holds significant therapeutic potential for human cancers.
  • Understanding TRAIL's signaling and regulation is crucial for its application.
  • TRAIL's dual role in cancer therapy and immune function warrants further investigation.